Sucralfate pp 163-173 | Cite as


Role of Endogenous Sulfhydryls and Basic Fibroblast Growth Factor (bFGF)
  • Sandor Szabo
  • Stefano Kusstatscher
  • Zsuzsa Sandor
  • Miki Nagata
  • Judah Folkman
  • Y. Shing


Sucralfate is a locally acting gastroprotective and antiulcer drug that exerts its effect in situ without substantial absorption into the systemic circulation. Nevertheless, endogenous mediators seem to play a role in the mechanism of action of sucralfate.


Gastric Mucosa Duodenal Ulcer Ulcer Healing Gastric Mucosal Injury Glandular Stomach 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nagashima R: Mechanisms of action of sucralfate. J Clin Gastroenterol 3:117–127, 1981. A good general overview of the mechanisms of action, emphasizing the early stages of research which are usually not covered in contemporary reviews.PubMedGoogle Scholar
  2. 2.
    Koba H, Yamamoto R, Nakano H: History of the development of sucralfate. Dig Dis Sci 35:A10, 1990. A brief summary of discovery and early development of sucralfate.Google Scholar
  3. 3.
    Hollander D, Tarnawski A: Protective effect of sucralfate on the gastric mucosa mediated by endogenous prostaglandins, in Szabo S, Mózsik G (eds): New Pharmacology of Ulcer Disease: Experimental and New Therapeutic Approaches. Amsterdam, Elsevier, 1987, pp 404–412. First review of the experimental data implicating mucosal prostaglandins in the acute gastroprotective effect of sucralfate.Google Scholar
  4. 4.
    Szabo S, Brown A: Prevention of ethanol-induced vascular injury and gastric mucosal lesions by sucralfate and its components: Possible role of endogenous sulfhydryls. Proc Soc Exp Biol Med 185:493–497, 1987. Rat study demonstrating that the gastroprotective action of sucralfate is mediated in part by a sulfhydryl-sensitive process counteracted by the sulfhydryl alkylator N-ethylmaleimide. It was also shown that sulfate and sucrose octasulfate are the most potent gastroprotective components of sucralfate, and that the early ethanol-induced vascular injury is preventable not only by sucralfate, but by its components as well, especially sulfates.PubMedGoogle Scholar
  5. 5.
    Nexo E, Poulsen SS: Does epidermal growth factor play a role in the action of sucralfate? Scand J Gastroenterol 22:45–49, 1987. First implications that epidermal growth factor may mediate part of the acute gastroprotection by sucralfate.Google Scholar
  6. 6.
    Folkman J, Szabo S, Shing Y: Sucralfate affinity for fibroblast growth factor. J Cell Biol 111:A203, 1990. Brief summary of first in vitro data demonstrating that bFGF binds not only to heparin, but also to sucralfate which structurally resembles heparin.Google Scholar
  7. 7.
    Folkman J, Szabo S, Stovroff M, et al: Duodenal ulcer: Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 214:414–426, 1991. Extensive in vitro and in vivo studies on sucralfate binding of bFGF, and demonstration of elevated level of bFGF in chronic duodenal ulcers treated with sucralfate in rats.PubMedCrossRefGoogle Scholar
  8. 8.
    Folkman J, Klagsbrun M: Angiogenic factors. Science 235:442–447, 1987. Review of peptides, steroids, and other molecules that influence angiogenesis.PubMedCrossRefGoogle Scholar
  9. 9.
    Szabo S, Vattay P, Morales RE, et al: Orally administered bFGF mutein: Effect on healing of chronic duodenal ulcers in rats. Dig Dis Sci 34:1323, 1989. First brief summary of experimental data demonstrating the potent ulcer healing effect of bFGF in the cysteamine-induced duodenal ulcer model.Google Scholar
  10. 10.
    Szabo S, Folkman J, Vattay P, et al: Duodenal ulcerogens: Effect of FGF on cysteamine-induced duodenal ulcer, in Halter F, Garner A, Tytgat GNJ (eds): Mechanisms of Peptic Ulcer Healing. London, Kluwer Academic Publishers, 1991, pp 139–150. Review of animal models of duodenal ulceration, and the first overview of the very potent ulcer healing properties of bFGF in rats with experimental duodenal ulcer.Google Scholar
  11. 11.
    Szabo S: The mode of action of sucralfate: The 1×1×1 mechanism of action. Scand J Gastroenterol 26:7–12, 1991. Detailed and critical review of the mechanisms of actions of sucralfate emphasizing that not all actions of the drug are equally important for acute gastroprotection and healing of chronic ulcers. It is proposed that prevention of vascular injury, maintenance of blood flow allowing rapid epithelial restitution are key mechanisms for acute gastroprotection, while local binding and concentration of growth factors such as bFGF and EGF are the key elements of stimulated chronic ulcer healing by sucralfate.CrossRefGoogle Scholar
  12. 12.
    Szabo S, Vattay P, Scarbrough E, et al: Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am J Med 91:158S–160S, 1991. Demonstration of enhanced angiogenesis and granulation tissue production in subcutaneously implanted sponges in rats: sucralfate was more potent than the water-soluble sucrose octasulfate, and less potent than pure bFGEPubMedCrossRefGoogle Scholar
  13. 13.
    Meister A: On the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol 44(suppl 10):1905–1915, 1992. General review of protective effect of sulfhydryls such as glutathione and vitamin C.PubMedCrossRefGoogle Scholar
  14. 14.
    Szabo S, Trier JS, Frankel PW: Sulfhydryl compounds may mediate gastric cytoprotection. Science 214:200–202, 1981. First in vivo demonstration that administration of sulfhydryls exerts acute gastroprotection in rats, while subcutaneous injection of sulfhydryl alkylators counteracted the “cytoprotection” by prostaglandins.PubMedCrossRefGoogle Scholar
  15. 15.
    Dupuy D, Szabo S: Protection by metals against ethanol-induced gastric mucosal injury in the rat. Comparative biochemical and pharmacologic studies implicate protein sulfhydryls. Gastroenterology 91:966–974, 1986. First demonstration that not only glutathione but protein sulfhydryls may have a role in the protection of gastric mucosa.PubMedGoogle Scholar
  16. 16.
    Nagata M, Sandor Z, Kusstatscher S, et al: Selective increase in glutathione concentration in gastric mucosa after sucralfate administration. Gastroenterology 1994 (in press). An abstract describing the selective elevation of mucosal glutathione concentration after a gastroprotective dose of sucralfate in rats.Google Scholar
  17. 17.
    Szabo S, Trier JS, Brown A, et al: Sulfhydryl blockers induce severe inflammatory gastritis in the rat. Gastroenterology 86:1271, 1984. Brief report on the induction of diffuse chronic erosive gastritis by ingesting sulfhydryl alkylators such as iodoacetamide in drinking water in rats.Google Scholar
  18. 18.
    Szabo S, Kusstatscher S, Stovroff M: Role of bFGF and angiogenesis in ulcer healing and the treatment of gastritis, in Domschke W, Konturek SJ (eds): The Stomach: Physiology, Pathophysiology and Treatment. Berlin, Springer-Verlag, 1993, pp 193–197. Brief review on the effect of oral treatment with bFGF and/or sucralfate in the treatment of experimental chronic gastritis induced by iodoacetamide in rats.Google Scholar
  19. 19.
    Sandor Z, Kusstatscher S, Karaoli T, et al: Synergistic angiogenesis after joint administration of sucralfate and bFGF in rats. FASEB J 1994 (in press). Abstract describing the first results on the synergistic angiogenesis by sucralfate and bFGF in the subcutaneous sponge assay in rats.Google Scholar

Copyright information

© Plenum Press 1995

Authors and Affiliations

  • Sandor Szabo
    • 1
  • Stefano Kusstatscher
    • 1
  • Zsuzsa Sandor
    • 1
  • Miki Nagata
    • 1
  • Judah Folkman
    • 2
  • Y. Shing
    • 2
  1. 1.Department of PathologyBrigham & Women’s Hospital, and Harvard Medical SchoolBoston
  2. 2.Department of SurgeryChildren’s Hospital, and Harvard Medical SchoolBoston

Personalised recommendations